ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
(Submit with Annual Report)
Enclosed is one copy of the completed Annual Reports due JUNE 1, 2014.
Please check:
X
Coordinator's Annual Report (due June 1)
X
SIG Minutes from Congress (previously submitted to C. DeMarco)
Sincerely,
___
Coordinator's Signature
Chemotherapy & Biotherapy (CHE)
Name of SIG
Meghan Routt
SIG Council Representative
June 1, 2014
Date
(Rev. 4/14)
1|P age
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
Chemotherapy & Biotherapy SIG of the Oncology Nursing Society. Reporting Period: JAN 1, 2013 to MAY 30, 2014.
Please list the leadership team (Work Group leaders/regional editors, etc.) and include their office or position. Due JUNE
1, 2014.
Position
Name
Street Address
SIG LEADERSHIP
City, State, ZIP
Email Address
Phone Numbers
Jonesboro, GA
30236
marty@polovich.com
404-4131171/W 404408-3890/H
(optional)
(optional)
8147 Masters
Court
Coordinator
Martha Polovich,
PhD RN AOCN
Coordinator-Elect
OPEN
Ex-Officio
Myra DavisAlston, RN MSN
Ed OCN CRNI
8615 Purple
Wisteria
Las Vegas, NV
89131-2511
myradalston@cox.net
Editor
Jeanne HeldWarmkessel,
MSN RN AOCN
ACNS-BC
Kristine Abueg,
RN MSN OCN
CBCN
110 Santa Anita
Dr
North Wales, PA
19454-4285
jeanne.heldwarmkessel@fccc.edu
702/791-9000 x
6251/W
702/8090621/H
215/728-2918/W
215/393-0796/H
1608 Apple Way
Roseville, CA
95747-4829
kdeano@hotmail.com
916/772-1511/H
Virtual Community
Administrator
Seth Eisenberg,
RN ASN OCN
34625 8th Ave SW
Federal Way,
WA 98023-8429
seisenbe@seattlecca.org
206/288-2064/W
253/709-5152/H
Regional
Representative
Catherine Hyzdik
New York NY
hydzikc@MSKCC.org
Regional
Representative
Karen Roesser
Richmond, VA
Karen.Roesser@HCAHelthcare.com
Regional
Representative
Millie Toth
Houston, TX
MATOTH@MDANDERSON.ORG
Regional
Representative
Robert Darnell
Lawton, OK
robert.darnell@ccswok.org
Biotherapy
Representative
713-201-9553/C
2|Page
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
SIG PURPOSES:
1. To support the mission statement of ONS.
2. To provide and promote a dynamic network for subspecialized nurses within ONS.
3. To serve as a forum for communication within the interest area.
4. To identify and explore patient care issues within the interest area.
5. To address current trends and issues within the interest area.
6. To share educational resources and clinical expertise with other Special Interest Groups,
various ONS Advisory Panels/Project Teams and the membership-at-large.
Chemotherapy & Biotherapy SIG of the Oncology Nursing Society. Covering the period from JAN 1, 2013 through
MAY 30, 2014. Due JUNE 1, 2014.
I. OVERVIEW OF THE PAST YEAR'S ACTIVITIES (as they relate to the purposes of SIGs): Please indicate
number of purpose to which activity relates.
Purpose Number
Activity
(see above)
1.
2.
2.
3.
4.
4.
5.
6.
Promoted excellence in oncology nursing by publishing the following articles in
the CHE SIG newsletter related to evidence-based practice: Chemotherapy
Dosing in Obese Oncology Patients; Chemotherapy Administration Sequencing;
Preventing CLABSI.
Promoted networking opportunities for the subspecialty of oncology nurses who
provide pharmacotherapy to patients through SIG meetings held at the 2013
ONS Congress (April), the 2013 Connections Conference (November), the 2014
ONS Congress (May).
Completed the merger of the Chemotherapy SIG and the Targeted & Biotherapy
SIG into Chemotherapy & Biotherapy SIG to consolidate efforts of each group.
Provides a forum for communication within the interest area through the Virtual
Community, the Chemotherapy & Biotherapy Discussion board, the SIG
Newsletter (January, May, August and October in 2013; March in 2014), e-mail
communiques (September 2013, March & May 2014); SIG leadership conference
call (July 2013).
Addressed patient care issues related to pharmacotherapy for cancer in the
following articles published in the CHE SIG newsletters: Chemotherapy Dosing in
Obese Patients; The Management of Chemotherapy Adverse Effects in Patients
with Cancer at Cancer Diseases Hospital in Zambia; Caring for Patients Taking
Oral Antineoplastic Agents.
Addressed patient care issues related to pharmacotherapy for cancer through the
following continuing education programs for members: Chemotherapy for NonOncology Indications (April 2013); Oral Chemotherapy Challenges (October 2013
& March 2014); Nursing-Sensitive Outcomes for Patients Receiving
Chemotherapy & Biotherapy (November 2013); Targeted Therapy Side Effects
(May 2014); Preventing Deadly Vinca Alkaloid Errors (May 2014); Chemotherapy
Induced Nausea and Vomiting Updates (May 2014).
Addressed the following current trends and issues related to Chemotherapy and
Biotherapy through the SIG Newsletter and the online Chemotherapy Discussion
Group: vesicant drug administration; chemotherapy dosing in obese patients;
preventing wrong-route drug administration; hazardous drug safe handling; new
drugs and indications; personalized medicine in oncology, updates to
ASCO/ONS Chemotherapy Safety Standards.
Shared SIG member expertise by the following activities: Sponsored Congress
sessions (2013 & 2014); consulted with members of new ONS Focus Group on
Oral Adherence; developed & displayed CHE SIG posters at Congress (2013 &
2014); provided input into draft position statement; provided information for
lobbying activities (hazardous drug safe handling & supervision during infusions).
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
II. CURRENT SIG PROJECTS:
If funded indicate source of funding.
a.
Completed since last annual report
 Planned & provided a web-facilitated education program for Chemotherapy & Biotherapy SIG members “Oral
Chemotherapy Challenges”. 1.0 contact hour of continuing nursing education credit was provide through
ONS (CE# 0101). Four sessions with a total attendance of 64 were held as follows:
Tuesday, October 8, 12:30 p.m. – 1:30 p.m. (ET)
Wednesday, October 16, 8:00 a.m. – 9:00 a.m. (ET)
Thursday, October 24, 7:00 p.m. – 8:00 p.m. (ET)
Saturday, October 26, 11:00 a.m. – 12:00 p.m. (ET)
The program was funded by an ONS SIG Project grant.
A 5th session of the program was repeated and offered to SIG members on March 11, 2014, sponsored by
the Nebraska Cancer Coalition. The number of attendees was 52.
 Published 4 SIG Newsletters
 Sent member communiques in October 2013, March 2014 and May 2014
 Held annual meetings at Congress in 2013 and 2014, including continuing education programs
 Held additional member meeting at Connections Conference in November 2013, including continuing
education program
 Surveyed annual meeting attendees regarding newsletter article topics (2014)
 Recruited annual meeting attendees to volunteer to author newsletter articles (2014)
 E-mailed invitations to SIG members who attended Leadership Development Institute to recruit future leaders
(2013)
b.
Ongoing projects (please indicate estimated date of completion)
 Surveyed annual meeting attendees (2014) regarding infection prevention practices related to IV port
access. Results will be published in future SIG newsletter
 Planning for SIG member needs assessment (fall 2014)
 Recruitment of candidates for Coordinator-elect position (August 1, 2014)
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
III. AWARDS:
SIG Leadership Submitted Award Nomination:
Award
Name
None
IV. Leadership Succession Planning
This is critical to the future success of the SIG.
a.
Have you identified future leaders within your SIG?
Yes
No
If so, who? Patricia Jakel, RN, MN, AOCN, UCLA Healthcare System

Additional SIG member also considering
If not, what is your plan to ensure future SIG leaders?
 Plan to e-mail members who have expressed interest in the past but did not meet criteria for
active membership
b.
What additional help from the Nominating Committee and/or staff do you require to help in this effort?
None
V. EDUCATIONAL ACTIVITIES AT CONGRESS, CONNECTIONS CONFERENCE for 2013 & 2014:
Number of Congress Submissions
Number of Connections Conference Submissions
Number of Discussion Sessions
Were any joint submissions?
2013
Were any joint submissions?
2014
Number of SIG-Sponsored sessions, actually presented:2013 CHE
2013 BIO
Number of SIG-Sponsored sessions, actually presented 2014
Number of submissions for other conferences
(Please indicate conference name)
SIG Poster
2013-2
2014-1
2013-0
2013-0
2014-0
CHE 1 w/Pharmaceutical/Industry Nurses
SIG & 1w/Staff Ed SIG
BIO 1w/Cancer Genetics SIG
1 w/Ambulatory/Office Nursing SIG
Congress – 2
Connections Congress – 2
Congress - 4
2013-1
2014-1
VI. LEADERSHIP COMMUNICATION: (3 time per year)
Please list dates of communication:
July 31, 2014
Conference call
September 12, 2013
Communique
March 8, 2014
Communique
April 29, 2014
VII. SIG PROJECT FUNDING MONIES/SEED MONEY/GRANTED THIS YEAR:

SIG Project Funding for web-facilitated conference
Communique
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
VIII.
LIST WORK GROUPS AND CHAIRS FORMED/ONGOING SINCE LAST ANNUAL REPORT AND THEIR
PURPOSES AND ACCOMPLISHMENTS:


IX.
Leaders of the Chemotherapy SIG met with leader from Targeted & Biotherapy SIG to discuss the need
for the merger of the two SIGs. Worked together to assess Biotherapy SIG members’ support for the
merger. Presented proposal to ONS Board. SIG approved in October, 2013. Established plan for
smooth transition, communication to members and revision of strategic plan based on needs of new
SIG.
Identified 2 additional regional representatives to assist with planning of web-based conference. Held
conference call in summer 2013.
LIST ANY RESEARCH PROJECTS THE SIG IS CURRENTLY INVOLVED WITH - INCLUDE BRIEF
DESCRIPTION OF EACH PROJECT:

None
X. PUBLISHED PLANNING MEETING MINUTES (year from last Congress):
PUBLISHED PLANNING MEETING AGENDA (year prior to last Congress):
YES
YES
NO
NO
XI. LIST STRENGTHS OF SIG:



Large membership
Current leadership experienced & dedicated to supporting SIG goals
Excellent newsletter; dedicated & skilled editor
XII. LIST OPPORTUNITIES FOR IMPROVEMENT WITHIN SIG:
(State how you are addressing these.)



Succession planning—continuing efforts to recruit new leaders include messages in every newsletter
and communique; personal contact of current leaders with future leaders.
Provide additional opportunities for continuing education using web-based programs—conference call
meeting planned in summer for fall program
Develop new logo for new Chemotherapy & Biotherapy SIG
ONCOLOGY NURSING SOCIETY
SIG COORDINATOR'S ANNUAL REPORT
XIII. SIG VIRTUAL COMMUNITY – LIST HOW YOU HAVE USED YOUR SITE






Provides a link to 2014 Congress presentation from SIG meeting for members to access slides
Provides information regarding Chemo SIG’s charter members during this the 25th anniversary of the
SIG
Provides information about targeted therapies
Posted several survey questions regarding chemotherapy-related practices
Provides links to useful forms, presentations, and articles of interest to SIG members
Provides links to the SIG newsletters
XIV. COLLABORATIONS (ONS, SIGS, ETC.):

CHEMO SIG coordinator met via conference calls with individuals interested in forming a focus group for
nurses interested in adherence to oral cancer therapy. Assisted in development of goals for the new
group.
XV. ADDITIONAL: COMMENTS, QUESTIONS, PROBLEMS, AND SOLUTIONS:
Completed by ONS Office
Membership
Number of SIG Members as of
MAY 31, 2014
Election in January 2013
Election in January 2014
NO
YES
Candidates:
Candidates:
SIG Leadership Workshop 2013
Attendance
NO
NO
Attendee:
CHE
BIO
SIG Strategic Goals
YES
Last Revision date:
7/13
(Rev. 4/14)
No candidates